[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey Esq.", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 56, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Henrietta  Ukwu FACP FRAPS, M.D.", "age": 57, "title": "Executive VP & Chief Regulatory Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 6, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.06, "open": 6.935, "dayLow": 6.9008, "dayHigh": 7.15, "regularMarketPreviousClose": 7.06, "regularMarketOpen": 6.935, "regularMarketDayLow": 6.9008, "regularMarketDayHigh": 7.15, "payoutRatio": 0.0, "beta": 2.295, "trailingPE": 3.4676616, "forwardPE": -43.5625, "volume": 3308069, "regularMarketVolume": 3308069, "averageVolume": 5224876, "averageVolume10days": 4899330, "averageDailyVolume10Day": 4899330, "bid": 6.9, "ask": 7.4, "bidSize": 2, "askSize": 1, "marketCap": 1147242880, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 11.55, "allTimeHigh": 331.68, "allTimeLow": 3.53, "priceToSalesTrailing12Months": 1.0775765, "fiftyDayAverage": 8.3438, "twoHundredDayAverage": 7.53355, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 620864000, "profitMargins": 0.32099, "floatShares": 136562530, "sharesOutstanding": 162498995, "sharesShort": 48322992, "sharesShortPriorMonth": 43445298, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.2974, "heldPercentInsiders": 0.087510005, "heldPercentInstitutions": 0.60762, "shortRatio": 11.05, "shortPercentOfFloat": 0.2985, "impliedSharesOutstanding": 164597260, "bookValue": -0.964, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": 341744992, "trailingEps": 2.01, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.583, "enterpriseToEbitda": 1.374, "52WeekChange": -0.109833956, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 6.97, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 12.88889, "targetMedianPrice": 11.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 762894016, "totalCashPerShare": 4.695, "ebitda": 451828000, "totalDebt": 251140000, "quickRatio": 1.854, "currentRatio": 2.267, "totalRevenue": 1064651008, "revenuePerShare": 6.595, "returnOnAssets": 0.18014, "grossProfits": 632619008, "freeCashflow": -455231136, "operatingCashflow": -378323008, "revenueGrowth": -0.166, "grossMargins": 0.59419996, "ebitdaMargins": 0.42439, "operatingMargins": -1.12684, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "twoHundredDayAverageChange": -0.56355, "twoHundredDayAverageChangePercent": -0.07480537, "priceToBook": -7.2302904, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.5 - Buy", "cryptoTradeable": false, "postMarketPrice": 7.0198, "postMarketChange": 0.049800396, "regularMarketChange": -0.0900002, "regularMarketDayRange": "6.9008 - 7.15", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 5224876, "fiftyTwoWeekLowChange": 1.9599996, "fiftyTwoWeekLowChangePercent": 0.39121747, "fiftyTwoWeekRange": "5.01 - 11.55", "fiftyTwoWeekHighChange": -4.5800004, "fiftyTwoWeekHighChangePercent": -0.39653683, "fiftyTwoWeekChangePercent": -10.983396, "dividendDate": 1557446400, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.01, "epsForward": -0.16, "epsCurrentYear": 2.07504, "priceEpsCurrentYear": 3.358971, "fiftyDayAverageChange": -1.3737998, "fiftyDayAverageChangePercent": -0.16464919, "corporateActions": [], "postMarketTime": 1763167553, "regularMarketTime": 1763154000, "regularMarketChangePercent": -1.27479, "regularMarketPrice": 6.97, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "postMarketChangePercent": 0.7144964, "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]